![Matthew Henn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Henn
Presidente presso
SERES THERAPEUTICS, INC.
Patrimonio netto: 57 374 $ in data 31/05/2026
Profilo
Matthew R.
Henn is currently Director at The Microbiome Therapeutics Innovation Group and President & Chief Scientific Officer at Seres Therapeutics, Inc. Former roles include Director at Viral Genomics, Inc. and Director-Viral Genomics at The Broad Institute, Inc. from 2005 to 2012.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of New Hampshire.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2026 | 7.838 ( 0,08% ) | 57 374 $ | 31/05/2026 |
Posizioni attive di Matthew Henn
| Società | Posizione | Inizio |
|---|---|---|
| SERES THERAPEUTICS, INC. | Presidente | 02/03/2026 |
Precedenti posizioni note di Matthew Henn
| Società | Posizione | Fine |
|---|---|---|
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01/06/2012 |
Viral Genomics, Inc. | Direttore/Membro del Consiglio | - |
Formazione di Matthew Henn
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
30
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
 University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viral Genomics, Inc. | |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
